[ANCA-associated small-vessel vasculitides]
A V Bayrashevskaya1, N D Degtyareva1, S G Radenska-Lopovok1,2
1I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia, Moscow, Russia.
Arkhiv Patologii
|February 15, 2022
Summary
Antineutrophil cytoplasmic antibody-associated vasculitides are systemic small-vessel diseases. This paper details their pathogenesis, focusing on the role of these antibodies in immune inflammation and presenting clinical features of specific conditions.
Area of Science:
- Rheumatology and Immunology
- Systemic Autoimmune Diseases
Background:
- ANCA-associated vasculitides (AAV) encompass systemic small-vessel inflammatory conditions.
- Antineutrophil cytoplasmic antibodies (ANCAs) play a critical role in the pathogenesis of AAV.
Purpose of the Study:
- To elucidate the role of ANCAs in the immune-mediated inflammation of blood vessels and tissues in AAV.
- To examine the pathogenesis of specific AAV subtypes, including granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA).
Main Methods:
- Review of existing literature on ANCA-associated vasculitides.
- Analysis of the immunological mechanisms driving vascular inflammation.
- Correlation of pathogenetic pathways with clinical and morphological disease presentations.
Main Results:
- ANCAs are central to the development of immune inflammation in AAV.
- Distinct pathogenetic pathways contribute to GPA and EGPA.
- Specific clinical and morphological features characterize these vasculitic conditions.
Conclusions:
- Understanding ANCA's role is crucial for comprehending AAV pathogenesis.
- The study highlights key differences and similarities in the pathogenesis and presentation of GPA and EGPA.
More Related Videos
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
67
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
67
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
49
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
49
Autoimmune Disorders
723
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
723
Genome-wide Association Studies-GWAS
14.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.5K


